Effect of Externally Implantable Tissue Expansion Device on Scar Length
Not Applicable
Withdrawn
- Conditions
- Skin Lesion
- Interventions
- Device: Externally Implantable Tissue Expansion Device
- Registration Number
- NCT00798798
- Lead Sponsor
- Northwestern University
- Brief Summary
The purpose of this study is to assess whether brief use of an externally implantable tissue expansion device following excisional skin cancer surgery will significantly reduce the diameter of the final wound defect, and hence the length of the final linear primary closure. The secondary objective is to assess the functional benefits, if any, associated with use of the tissue expander.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Implantable Tissue Expansion Device Externally Implantable Tissue Expansion Device Will apply externally implantable tissue expansion device for 2 days
- Primary Outcome Measures
Name Time Method Surface area (in cm2) of subject's scar 3 months
- Secondary Outcome Measures
Name Time Method Treating physicians will note any adverse effects 3 months
Trial Locations
- Locations (1)
Northwestern University Dermatology
🇺🇸Chicago, Illinois, United States